Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer's Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer's Day Life Science Investing
PVG Asset Management Announces Plan for First 100 Days at Anavex Life Sciences Life Science Investing
Arcturus Therapeutics to Present Ornithine Transcarbamylase Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform Life Science Investing
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing Nanotech Investing
Marvel Biosciences Provides Update on Private Placement for up to $3.0 Million Life Science Investing
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN Life Science Investing
argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors Biotech Investing
Glass Lewis Recommends Anavex Stockholders Vote the GOLD Universal Proxy Card, Citing "Functionally Inert Stewardship" in Support of PVG Asset Management's Call for Change Life Science Investing
Niagen Bioscience Engages Veteran Pharmaceutical Executives and Biotechnology Experts to Support Drug Development Program and Strategic Business Growth Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
